Home › Funds › PERCEPTIVE ADVISORS LLC › CRVS
PERCEPTIVE ADVISORS LLC position in CRVS
CORVUS PHARMACEUTICALS I · Health Care
PERCEPTIVE ADVISORS LLC reported holding 2,667,441 shares of CRVS (CORVUS PHARMACEUTICALS I) in its Q2 2026 13F filing — a position valued at US$39.9M, representing 0.63% of its reported portfolio and ranking #35 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed CRVS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's CRVS position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in CRVS in Q2 2025 at 1,438,595 shares (US$5.8M). The position peaked in Q2 2026 at 2,667,441 shares, worth US$39.9M. Across 5 filings, PERCEPTIVE ADVISORS LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,667,441 shares valued at US$39.9M — an increase of 375,000 shares quarter over quarter.. Notable position changes include a 52% trim in Q4 2025 (shares rose 90% over the following quarter), a 231% increase in Q1 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 1.44M | $5.75M | New |
| Q3 2025 | 1.44M | $10.60M | Hold |
| Q4 2025 | 692.44K | $5.33M | Reduce |
| Q1 2026 | 2.29M | $33.54M | Add |
| Q2 2026 | 2.67M | $39.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRVS and 13F data
CRVS (CORVUS PHARMACEUTICALS I) is a Health Care company. 72 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), ADAMS STREET PARTNERS LLC (US$48.9M), Vivo Capital, LLC (US$41.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRVS
- ORBIMED ADVISORS LLC 7.17M sh · $107.05M · Q2 2026
- ADAMS STREET PARTNERS LLC 3.28M sh · $48.94M · Q2 2026
- Vivo Capital, LLC 2.81M sh · $41.92M · Q2 2026
- Deep Track Capital, LP 2.49M sh · $37.23M · Q2 2026
- BRAIDWELL LP 2.13M sh · $31.77M · Q2 2026
- Foresite Capital Management VI LLC 1.83M sh · $27.36M · Q2 2026
- Boxer Capital Management, LLC 1.10M sh · $16.43M · Q2 2026
- Catalio Capital Management, LP 1.08M sh · $16.15M · Q2 2026
- Eversept Partners, LP 747.99K sh · $11.18M · Q2 2026
- DCF Advisers, LLC 637.50K sh · $9.52M · Q2 2026
- Blue Owl Capital Holdings LP 608.60K sh · $9.09M · Q2 2026
- Nextech Invest Ltd. 450.00K sh · $6.72M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held CRVS?
PERCEPTIVE ADVISORS LLC has disclosed CRVS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is PERCEPTIVE ADVISORS LLC's current position in CRVS?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 2.67M shares of CRVS (CORVUS PHARMACEUTICALS I), valued at $39.85M, representing 0.63% of its reported portfolio and ranking #35.
Has PERCEPTIVE ADVISORS LLC been buying or selling CRVS?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in CRVS. The position peaked in Q2 2026 at 2.67M shares.
Which other funds hold CRVS?
Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, Vivo Capital, LLC, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.